|
시장보고서
상품코드
2055215
프리필드 시린지 시장 : 재료별, 약제 유형별, 설계별, 제품 유형별, 사용성별, 제조 방법별, 최종사용자별, 지역별Prefilled Syringes Market, By Material, By Drug Type, By Design, By Product Type, By Usability, By Manufacturing Method, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
프리필드 시린지 시장은 2026년 76억 달러로 추정되고, 2033년에 112억 7,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR5.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 76억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 5.80% | 2033년 시장 규모 예측 : | 112억 7,000만 달러 |
프리필드 시린지란, 주사할 약물이 미리 채워져 있는 일회용 주사기를 말합니다. 이 제품은 제조업체에서 바늘이 부착된 1회 투여용 약제입니다. 이 주사기들은 미리 채워져 있으므로, 간호사나 환자가 약물을 준비하여 바늘에 주입할 필요가 없습니다. 대신, 주사기 내에 이미 적정 용량이 채워져 있어 신속하게 주사할 수 있습니다. 또한, 프리필드 시린지는 정밀도가 높아 더욱 안전하게 사용할 수 있습니다. 일부 프리필드 시린지의 카트리지는 자가흡입식 주사기에 맞도록 제작되어, 플런저를 누를 필요 없이 피부를 관통하여 약물을 투여합니다. 이를 통해 투여량이 원활하게 공급되며, 주사액이 적절한 깊이까지 도달하도록 보장됩니다.
시장 역학
만성 질환 유병률 증가는 치료 수단으로서 프리필드 시린지에 대한 수요를 견인하고 있으며, 이는 예측 기간 동안 시장 성장을 뒷받침할 것으로 예측됩니다. 예를 들어, 2022년 7월에 업데이트된 미국 질병통제예방센터(CDC)의 만성 질환 관련 데이터에 따르면, 미국 성인의 약 60%가 어떤 형태의 만성 질환을 앓고 있으며, 40% 이상의 성인이 두 가지 이상의 만성 질환을 앓고 있습니다. 암은 전 세계적으로 가장 흔한 만성 질환입니다. 예를 들어, GLOBOCAN 2021 보고서에 따르면, 2021년 전 세계 암 환자 수는 약 1,929만 2,789명에 달했습니다. 이 수치는 2040년까지 2,888만 7,940건으로 증가할 것으로 추정됩니다. 일부 유형의 암은 신약이나 생물학적 제제를 사용하여 치료되고 있으며, 이에 따라 2026년부터 2033년까지의 예측 기간 동안 프리필드 시린지 수요가 증가할 것으로 예측됩니다. 따라서 전 세계적으로 증가하는 암 환자 수는 예측 기간 동안 프리필드 시린지 시장의 성장을 견인할 것으로 예측됩니다.
시장에 진입한 기업들의 제품 포트폴리오 확대를 위한 각 규제 당국의 승인 건수 증가가 예측 기간 동안 시장 성장을 견인할 것으로 전망됩니다. 예를 들어, 2022년 12월, 다국적 제약 기업인 Alembic Pharmaceuticals Limited는 1회 투여용 프리필드 시린지(250mg/5mL(50mg/mL)) 형태의 풀베스트란트 주사액에 대한 약품허가신청서(ANDA)에 대해 미국 식품의약국(FDA)으로부터 최종 승인을 획득했다고 발표했습니다. 풀베스트란트 주사액은 유방암 치료에 사용되는 에스트로겐 수용체 길항제입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 제약 요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 프리필드 시린지 시장의 주요 기업 프로파일을 발표하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 프리필드 시린지 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 프리필드 시린지 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 프리필드 시린지 시장 : 재료별, 2026-2033년
제5장 세계의 프리필드 시린지 시장 : 약제 유형별, 2026-2033년
제6장 세계의 프리필드 시린지 시장 : 설계별, 2026-2033년
제7장 세계의 프리필드 시린지 시장 : 제품 유형별, 2026-2033년
제8장 세계의 프리필드 시린지 시장 : 사용성별, 2026-2033년
제9장 세계의 프리필드 시린지 시장 : 제조 방법별, 2026-2033년
제10장 세계의 프리필드 시린지 시장 : 최종사용자별, 2026-2033년
제11장 세계의 프리필드 시린지 시장 : 지역별, 2026-2033년
제12장 경쟁 구도
제13장 섹션
LSH 26.06.23Prefilled Syringes Market is estimated to be valued at USD 7.60 Bn in 2026 and is expected to reach USD 11.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.60 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 11.27 Bn |
Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.
Market Dynamics
Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2021 report, the total number of people in the world affected by cancer in 2021 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period 2026 - 2033. Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.
The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market
Market Segmentation
- Global Prefilled Syringes Market, By Material (Revenue, USD Bn, 2021 - 2033)
- Glass
- Plastic/Polymer
- Global Prefilled Syringes Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Biologics
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
- Vaccines
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
- Insulin
- Anticoagulants
- Flush Saline Syringes
- Others
- Global Prefilled Syringes Market, By Design (Revenue, USD Bn, 2021 - 2033)
- Single-chamber
- Dual-chamber
- Multi-chambered
- Global Prefilled Syringes Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Staked in-needle pre-filled syringes
- Needle-free pre-filled syringes
- Global Prefilled Syringes Market, By Usability (Revenue, USD Bn, 2021 - 2033)
- Disposable
- Reusable
- Global Prefilled Syringes Market, By Manufacturing Method (Revenue, USD Bn, 2021 - 2033)
- Captive
- Merchant
- Global Prefilled Syringes Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
- Global Prefilled Syringes Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Gerresheimer AG
- Becton, Dickinson and Company
- West Pharmaceutical Services, Inc.
- Terumo Corporation
- Nipro Europe Group Companies
- B. Braun SE
- Sanofi
- GSK plc.
- Pfizer Inc.
- Bayer AG
- Polymedicure
- Amsino International, Inc.
- Leeford Healthcare Limited
- Torrent Pharmaceuticals Ltd.
- Regeneron Pharmaceuticals Inc.
- Ypsomed AG
- SOL-Millennium
- Stevanato Group S.p.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Material
- Market Snapshot, By Drug Type
- Market Snapshot, By Design
- Market Snapshot, By Product Type
- Market Snapshot, By Usability
- Market Snapshot, By Manufacturing Method
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- Service Cost Analysis
4. Global Prefilled Syringes Market, By Material, 2026-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Plastic/Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
5. Global Prefilled Syringes Market, By Drug Type, 2026-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
- Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Flush Saline Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
6. Global Prefilled Syringes Market, By Design, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Single-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Dual-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Multi-chambered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
7. Global Prefilled Syringes Market, By Product Type, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Staked in-needle pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Needle-free pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
8. Global Prefilled Syringes Market, By Usability, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
9. Global Prefilled Syringes Market, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Captive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Merchant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
10. Global Prefilled Syringes Market, By End User, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segments Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
11. Global Prefilled Syringes Market, By Region, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
12. Competitive Landscape
- Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- West Pharmaceutical Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nipro Europe Group Companies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B.Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Polymedicure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amsino International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Leeford Healthcare Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL-Millennium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stevanato Group S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
13. Section
- Research Methodology
- About Us
